LEMAITRE VASCULAR INC (LMAT) Stock Overview
USA - NASDAQ:LMAT - US5255582018 - Common Stock
LMAT Key Statistics, Chart & Performance
The current stock price of LMAT is 85.11 USD. In the past month the price decreased by -7.85%. In the past year, price decreased by -4.26%.
LMAT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.9 | 229.39B | ||
| ISRG | INTUITIVE SURGICAL INC | 54.54 | 157.38B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.15 | 143.20B | ||
| SYK | STRYKER CORP | 28.35 | 139.27B | ||
| MDT | MEDTRONIC PLC | 16.94 | 120.16B | ||
| BDX | BECTON DICKINSON AND CO | 12.55 | 51.34B | ||
| IDXX | IDEXX LABORATORIES INC | 51.38 | 49.36B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.09 | 43.89B | ||
| RMD | RESMED INC | 27.76 | 38.82B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.06 | 32.04B | ||
| DXCM | DEXCOM INC | 39.73 | 26.48B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.73 | 25.60B |
Related stock screener links
About LMAT
Company Profile
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company is headquartered in Burlington, Massachusetts and currently employs 651 full-time employees. The company went IPO on 2006-10-19. The firm develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. The company also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
Company Info
LEMAITRE VASCULAR INC
63 2nd Ave
Burlington MASSACHUSETTS 01803 US
CEO: George W. LeMaitre
Employees: 651
Phone: 17812212266
LEMAITRE VASCULAR INC / LMAT FAQ
What is the stock price of LEMAITRE VASCULAR INC today?
The current stock price of LMAT is 85.11 USD. The price decreased by -3.06% in the last trading session.
What is the ticker symbol for LEMAITRE VASCULAR INC stock?
The exchange symbol of LEMAITRE VASCULAR INC is LMAT and it is listed on the Nasdaq exchange.
On which exchange is LMAT stock listed?
LMAT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for LEMAITRE VASCULAR INC stock?
17 analysts have analysed LMAT and the average price target is 106.87 USD. This implies a price increase of 25.57% is expected in the next year compared to the current price of 85.11. Check the LEMAITRE VASCULAR INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is LEMAITRE VASCULAR INC worth?
LEMAITRE VASCULAR INC (LMAT) has a market capitalization of 1.93B USD. This makes LMAT a Small Cap stock.
How many employees does LEMAITRE VASCULAR INC have?
LEMAITRE VASCULAR INC (LMAT) currently has 651 employees.
What are the support and resistance levels for LEMAITRE VASCULAR INC (LMAT) stock?
LEMAITRE VASCULAR INC (LMAT) has a support level at 82.31 and a resistance level at 90.31. Check the full technical report for a detailed analysis of LMAT support and resistance levels.
Is LEMAITRE VASCULAR INC (LMAT) expected to grow?
The Revenue of LEMAITRE VASCULAR INC (LMAT) is expected to grow by 13.91% in the next year. Check the estimates tab for more information on the LMAT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy LEMAITRE VASCULAR INC (LMAT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of LMAT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of LMAT, evaluating the profitability, health, valuation and growth aspects
- LEMAITRE VASCULAR INC (LMAT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- LEMAITRE VASCULAR INC (LMAT) Sales and EPS estimates to see what analysts future expectations are.
- LEMAITRE VASCULAR INC (LMAT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- LEMAITRE VASCULAR INC (LMAT) Insider and Institutional Ownership to learn about the owners and their transactions.
- LEMAITRE VASCULAR INC (LMAT) Stock Chart to make your own analysis
- LEMAITRE VASCULAR INC (LMAT) Latest news and press-releases to stay up to date.
Does LEMAITRE VASCULAR INC (LMAT) stock pay dividends?
LEMAITRE VASCULAR INC (LMAT) has a dividend yield of 0.86%. The yearly dividend amount is currently 0.64. Check the full fundamental report for a detailed analysis of LMAT dividend history, reliability and sustainability.
When does LEMAITRE VASCULAR INC (LMAT) report earnings?
LEMAITRE VASCULAR INC (LMAT) will report earnings on 2025-10-29, after the market close.
What is the Price/Earnings (PE) ratio of LEMAITRE VASCULAR INC (LMAT)?
The PE ratio for LEMAITRE VASCULAR INC (LMAT) is 41.32. This is based on the reported non-GAAP earnings per share of 2.06 and the current share price of 85.11 USD. Check the full fundamental report for a full analysis of the valuation metrics for LMAT.
What is the Short Interest ratio of LEMAITRE VASCULAR INC (LMAT) stock?
The outstanding short interest for LEMAITRE VASCULAR INC (LMAT) is 6.46% of its float. Check the ownership tab for more information on the LMAT short interest.
LMAT Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to LMAT. When comparing the yearly performance of all stocks, LMAT turns out to be only a medium performer in the overall market: it outperformed 41.58% of all stocks.
LMAT Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to LMAT. LMAT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
LMAT Financial Highlights
Over the last trailing twelve months LMAT reported a non-GAAP Earnings per Share(EPS) of 2.06. The EPS increased by 23.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.08% | ||
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| Debt/Equity | 0.46 |
LMAT Forecast & Estimates
17 analysts have analysed LMAT and the average price target is 106.87 USD. This implies a price increase of 25.57% is expected in the next year compared to the current price of 85.11.
For the next year, analysts expect an EPS growth of 20.02% and a revenue growth 13.91% for LMAT